X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+ hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice

Archives of Physiology and Biochemistry

Volumn 117, Issue 1, 2011, Pages 1-7

  Givvimani, S ^a   Sen, U ^a   Tyagi, N ^a   Munjal, C ^a   Tyagi, S C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Angiography; Angiostatin; Capillary rarefaction; Endostatin; Heart; Hyperglycaemia; Liver; Lung; Mesentery; Portal circulation; Remodelling; Renal

Indexed keywords

BARIUM SULFATE; CYSTATHIONINE BETA SYNTHASE; GELATINASE B; PROTEINASE ACTIVATED RECEPTOR 1;

ANGIOGRAPHY; ANIMAL; ARTICLE; BLOOD VESSEL; BRAIN; C57BL MOUSE; DISEASE MODEL; GENETICS; HYPERHOMOCYSTEINEMIA; KIDNEY CIRCULATION; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; SPLANCHNIC BLOOD FLOW; TRANSGENIC MOUSE; VASCULARIZATION; X RAY;

ANGIOGRAPHY; ANIMALS; BARIUM SULFATE; BLOOD VESSELS; BRAIN; CYSTATHIONINE BETA-SYNTHASE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HYPERHOMOCYSTEINEMIA; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SIZE; RECEPTOR, PAR-1; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; X-RAYS;

MUS;

EID: 78651230951     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2010.512042     Document Type: Article

References (28)

1. Archiniegas E, Neves CY, Candelle D, CARDIER JE. (2004). Thrombin and its protease-activated receptor-1 (PAR1) participate in the endothelial-mesenchymal transdifferentiation process. DNA Cell Biol 23:815-25.
2. Beckmann N. (2000). High resolution magnetic resonance angiography non-invasively reveals mouse strain differences in the cerebrovascular anatomy in vivo. Magn Reson Med 44:252-8.
3. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE. (2007). Collateral density, remodelling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics 30:179-91.
4. Conant K, Haughey N, Nath A, St Hillaire C, Gary DS, Pardo CA, Wahl LM, Bilak M, Milward E, Mattson MP. (2002). Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase- 9. J Neurochem 82:885-93.
5. Davis G, Baboolal N, Nayak S, McRae A. (2009). Sialic acid, homocysteine and CRP: potential markers for dementia. Neurosci Lett 465:282-4.
6. Distrutti E, Mencarelli A, Santucci L, Renga B, Orlandi S, Donini A, Shah V, Fiorucci S. (2008). The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology 47:659-67.
7. Gibbons GH, Dzau VJ. (1994). The emerging concept of vascular remodelling. N Engl J Med 330:1431-8.
8. Givvimani S, Tyagi N, Sen U, Mishra PK, Qipshidze N, Munjal C, Vacek JC, Abe OA, Tyagi SC. (2010). MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure. Arch Physiol Biochem 116:63-72.
9. Gorgone G, Ursini F, Altamura C, Bressi F, Tombini M, Curcio G, Chiovenda P, Squitti R, Silvestrini M, Ientile R, Pisani F, Rossini PM, Vernieri F. (2009). Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: a correlation study in patients with cognitive impairment. Atherosclerosis 206:309-13.
10. Guo YH, Chen FY, Wang GS, Chen L, Gao W. (2008). Diet-induced hyperhomocysteinemia exacerbates vascular reverse remodeling of balloon-injured arteries in rat. Chin Med J (Engl) 121:2265-71.
11. Hao F, Yu JD. (2003). High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells. Acta Pharmacol Sin 24:534-8.
12. Kivipelto M, Annerbo S, Hultdin J, Backman L, Viitanen M, Fratiglioni L, Lokk J. (2009). Homocysteine and holo- transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol 16:808-13.
13. Kumar M, Tyagi N, Moshal KS, Sen U, Kundu S, Mishra PK, Givvimani S, Tyagi SC. (2008). Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. Neurochem Int 53:214-9.
14. MacFarlane, SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. (2001). Proteinase-activated receptors. Pharmacol Rev 53:245-82.
15. Maeda K, Hata R, Hossmann KA. (1999). Regional metabolic disturbances and cerebrovascular anatomy after permanent middle cerebral artery occlusion in C57black/6 and SV129 mice. Neurobiol Dis 6:101-8. (Pubitemid 29233326)
16. Myojin K, Taguchi A, Umetani K, Fukushima K, Nishiura N, Matsuyama T, Kimura H, Stern DM, Imai Y, Mori H. (2007). Visualization of intracerebral arteries by synchrotron radiation microangiography. AJNR Am J Neuroradiol 28:953-7.
17. Nilsson K, Gustafson L, Hultberg B. (2008). Plasma homocysteine and vascular disease in elderly patients with mental illness. Clin Chem Lab Med 46:1556-61.
18. Ota R, Kurihara C, Tsou TL, Young WL, Yeghiazarians Y, Chang M, Mobashery S, Sakamoto A, Hashimoto T. (2009). Roles of matrix metalloproteinases in flow-induced outward vascular remodelling. J Cereb Blood Flow Metab 29:1547-58.
19. Ovechkin AV, Tyagi N, Sen U, Lominadze D, Steed MM, Moshal KS, Tyagi SC. (2006). 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice. Am J Physiol Lung Cell Mol Physiol 291:L905-11.
20. Rajkumar V, Ragatzki P, Sima A, Levy J. (1999). Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infarctions: implications for therapy. Endocrine 11:57-60.
21. Regalado Dona PJ, Azpiazu Artigas P, Sanchez Guerra ML, Almenar Monfort C. (2009). Vascular risk factors and Alzheimers disease. Rev Esp Geriatr Gerontol 44:98-105.
22. Sala I, Belen Sanchez-Saudinos M, Molina-Porcel L, Lazaro E, Gich I, Clarimon J, Blanco-Vaca F, Blesa R, Gomez-Isla T, Lleo A. (2008). Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Dement Geriatr Cogn Disord 26:506-12.
23. Sasaki N, Yamashita T, Takaya T, Shinohara M, Shiraki R, Takeda M, Emoto N, Fukatsu A, Hayashi T, Ikemoto K, Nomura T, Yokoyama M, Hirata K, Kawashima S. (2008). Augmentation of vascular remodelling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Arterioscler Thromb Vasc Biol 28:1068-76.
24. Shastry S, Tyagi SC. (2004). Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells. J Cell Biochem 93:207-13.
25. Song W, Ergul A. (2006). Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size. Cardiovasc Diabetol 5:3.
26. Tsopanoglou NE, Maragoudakis ME. (2007). Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1. Semin Thromb Hemost 33:680-87.
27. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, Harrison DG, Tsao PS. (2001). Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88:1291-8.
28. Zalev AH. (1997). Venous barium embolization, a rare, potentially fatal complication of barium enema: 2 case reports. Can Assoc Radiol J 48:323-6.